| Full Name | Abra Seidler |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1531 S Madison St, Appleton, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689063950 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 6095 (Wisconsin) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 167888 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascension Medical Group-fox Valley Wisconsin Inc | 0244142420 | 258 |
News Archive
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Vaccine skepticism among young adults may stall efforts to achieve herd immunity - a threshold in which approximately 80 percent of a population is vaccinated against the coronavirus.
The physical forces that guide how cells migrate-how they manage to get from place to place in a coordinated fashion inside the living body- are poorly understood. Scientists at the Harvard School of Public Health and the Institute for Bioengineering of Catalonia have, for the first time, devised a way to measure these forces during collective cellular migration.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
Approximately 500,000 Americans require dialysis to treat kidney disease; of that population nearly half of the deaths that occur are caused by cardiovascular disease. Dialysis patients are at elevated risk for sudden cardiac death, but physicians are unclear why these deaths occur because little research has been done to examine how to best manage heart disease in this high-risk population.
› Verified 3 days ago
| Entity Name | Ascension Medical Group-fox Valley Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730126392 PECOS PAC ID: 0244142420 Enrollment ID: O20031105000351 |
News Archive
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Vaccine skepticism among young adults may stall efforts to achieve herd immunity - a threshold in which approximately 80 percent of a population is vaccinated against the coronavirus.
The physical forces that guide how cells migrate-how they manage to get from place to place in a coordinated fashion inside the living body- are poorly understood. Scientists at the Harvard School of Public Health and the Institute for Bioengineering of Catalonia have, for the first time, devised a way to measure these forces during collective cellular migration.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
Approximately 500,000 Americans require dialysis to treat kidney disease; of that population nearly half of the deaths that occur are caused by cardiovascular disease. Dialysis patients are at elevated risk for sudden cardiac death, but physicians are unclear why these deaths occur because little research has been done to examine how to best manage heart disease in this high-risk population.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Abra Seidler, 1531 S Madison St, Appleton, WI 54915-1800 Ph: (920) 730-4411 | Abra Seidler, 1531 S Madison St, Appleton, WI 54915 Ph: (920) 730-4411 |
News Archive
Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.
Vaccine skepticism among young adults may stall efforts to achieve herd immunity - a threshold in which approximately 80 percent of a population is vaccinated against the coronavirus.
The physical forces that guide how cells migrate-how they manage to get from place to place in a coordinated fashion inside the living body- are poorly understood. Scientists at the Harvard School of Public Health and the Institute for Bioengineering of Catalonia have, for the first time, devised a way to measure these forces during collective cellular migration.
In a genome sequencing study of 74 neuroblastoma tumors in children, scientists at the Johns Hopkins Kimmel Cancer Center and the Children's Hospital of Philadelphia (CHOP) found that patients with changes in two genes, ARID1A and ARID1B, survive only a quarter as long as patients without the changes. The discovery could eventually lead to early identification of patients with aggressive neuroblastomas who may need additional treatments.
Approximately 500,000 Americans require dialysis to treat kidney disease; of that population nearly half of the deaths that occur are caused by cardiovascular disease. Dialysis patients are at elevated risk for sudden cardiac death, but physicians are unclear why these deaths occur because little research has been done to examine how to best manage heart disease in this high-risk population.
› Verified 3 days ago
Ann M Hefter, AGACNP-BC, MSN, BSN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-731-8900 | |
Dessia J Laxton-reinke, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-731-8900 Fax: 920-738-5369 | |
Katie Geiser, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5045 W Grande Market Dr, Appleton, WI 54913 Phone: 920-886-9380 | |
Lisa Valiquette, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2500 E Capitol Dr, Appleton, WI 54911 Phone: 920-738-4600 Fax: 920-738-4792 | |
Kimberly A Romenesko, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-735-7645 Fax: 920-735-7618 | |
Steven R Hamel, APN FP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 | |
Ms. Zoua Yang, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1818 N Meade St, Appleton, WI 54911 Phone: 920-731-4101 |